Institutional Ownership Moon Lake Immunotherapeutics (MLTX)
This table provides information about the institutional ownership of Moon Lake Immunotherapeutics (MLTX). We have compiled data on the 135 institutions that hold shares in the stock, with a total of 56 Million shares, which have been reported (via 13F filing form) to have a value of $2.23 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Bvf Inc
San Francisco, CA |
May 15, 2024 Q1 2024 |
21,751,284
shares
|
$865 Million
32.73% of portfolio
|
Q2 2022
New holding
|
|
|
Cormorant Asset Management, LP
Boston, MA |
May 15, 2024 Q1 2024 |
8,494,151
shares
|
$338 Million
24.56% of portfolio
|
Q4 2023
Added 4.32%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
2,580,000
shares
|
$103 Million
1.56% of portfolio
|
Q4 2023
Added 29.0%
|
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
May 15, 2024 Q1 2024 |
2,309,433
shares
|
$91.8 Million
0.02% of portfolio
|
Q1 2024
Added 14.97%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
May 15, 2024 Q1 2024 |
2,284,913
shares
|
$90.8 Million
0.23% of portfolio
|
Q1 2024
Added 49.76%
|
|
|
Price T Rowe Associates Inc
Baltimore, MD |
May 15, 2024 Q1 2024 |
2,135,883
shares
|
$84.9 Million
0.01% of portfolio
|
Q1 2024
Reduced 7.7%
|
|
|
Holocene Advisors, LP
New York, NY |
May 15, 2024 Q1 2024 |
1,454,869
shares
|
$57.8 Million
0.28% of portfolio
|
Q1 2024
Added 51.34%
|
|
|
Federated Hermes, Inc.
Pittsburgh, PA |
May 14, 2024 Q1 2024 |
1,099,756
shares
|
$43.7 Million
0.13% of portfolio
|
Q1 2024
Added 3.7%
|
|
|
T. Rowe Price Investment Management, Inc.
Baltimore, MD |
May 15, 2024 Q1 2024 |
1,095,101
shares
|
$43.5 Million
0.03% of portfolio
|
Q1 2024
Reduced 10.28%
|
|
|
Alliancebernstein L.P.
New York, NY |
May 14, 2024 Q1 2024 |
955,507
shares
|
$38 Million
0.02% of portfolio
|
Q1 2024
Added 5.1%
|
|
|
Westfield Capital Management CO LP
Boston, MA |
May 10, 2024 Q1 2024 |
910,873
shares
|
$36.2 Million
0.24% of portfolio
|
Q1 2024
Added 48.82%
|
|
|
Pictet Asset Management Sa
Geneva 73, V8 |
Aug 10, 2023 Q2 2023 |
894,005
shares
|
$35.5 Million
0.05% of portfolio
|
Q2 2023
New holding
|
|
|
Polar Capital Holdings PLC
London, X0 |
May 15, 2024 Q1 2024 |
857,957
shares
|
$34.1 Million
0.27% of portfolio
|
Q1 2024
Reduced 8.45%
|
|
|
Fred Alger Management, LLC
New York, NY |
May 15, 2024 Q1 2024 |
666,722
shares
|
$26.5 Million
0.17% of portfolio
|
Q1 2024
Reduced 17.75%
|
|
|
Marshall Wace, LLP
London, X0 |
May 15, 2024 Q1 2024 |
510,946
shares
|
$20.3 Million
0.04% of portfolio
|
Q1 2024
New holding
|
|
|
Pictet Asset Management Holding Sa
Carouge, V8 |
May 14, 2024 Q1 2024 |
499,841
shares
|
$19.9 Million
0.03% of portfolio
|
Q1 2024
Reduced 18.93%
|
|
|
Balyasny Asset Management LLC
Chicago, IL |
May 13, 2024 Q1 2024 |
424,695
shares
|
$16.9 Million
0.04% of portfolio
|
Q1 2024
Reduced 29.04%
|
|
|
Black Rock Inc.
New York, NY |
May 10, 2024 Q1 2024 |
408,280
shares
|
$16.2 Million
0.0% of portfolio
|
Q1 2024
Added 6.96%
|
|
|
Finepoint Capital LP
Boston, MA |
May 14, 2024 Q1 2024 |
360,916
shares
|
$14.3 Million
4.98% of portfolio
|
Q1 2024
Reduced 59.67%
|
|
|
Perceptive Advisors LLC
New York, NY |
May 15, 2024 Q1 2024 |
339,012
shares
|
$13.5 Million
0.36% of portfolio
|
Q1 2024
Added 311.43%
|
|
|
Ghost Tree Capital, LLC
New York, NY |
May 15, 2024 Q1 2024 |
300,000
shares
|
$11.9 Million
4.86% of portfolio
|
Q1 2024
Added 275.0%
|
|
|
Bio Impact Capital LLC
Cambridge, MA |
May 15, 2024 Q1 2024 |
296,050
shares
|
$11.8 Million
2.43% of portfolio
|
Q1 2024
Added 0.5%
|
|
|
5 Am Venture Management, LLC
San Francisco, CA |
May 15, 2024 Q1 2024 |
282,313
shares
|
$11.2 Million
5.0% of portfolio
|
Q1 2024
Reduced 6.71%
|
|
|
Wellington Management Group LLP
Boston, MA |
May 15, 2024 Q1 2024 |
276,439
shares
|
$11 Million
0.0% of portfolio
|
Q1 2024
New holding
|
|
|
Candriam S.C.A.
|
May 03, 2024 Q1 2024 |
239,000
shares
|
$9.5 Million
0.08% of portfolio
|
Q1 2024
Added 29.19%
|
|